Fibromyalgia: placebo has moderate effect size
Access to the full content of this site is available only to registered healthcare professionals.
Register to read more
Why this matters
- A meta-analysis has found a moderate effect size for placebo across 124 randomized controlled trials (RCTs).
- Because of the paucity of effective treatments for fibromyalgia, clinicians can harness the placebo effect in their clinical practice.
- Meta-analysis was conducted on 124 RCTs (n=15,633).
- The placebo effect was calculated by comparing changes with placebo vs no-treatment control groups.
- Funding: Arthritis Research UK.
- Placebo patients had significantly better improvements in pain, fatigue, sleep quality, physical function, and other outcomes relative to no treatment.
- The magnitude of the effect size (ES) for pain relief was 0.52. ...